The U.S. Food and Drug Administration approved a new nasal spray on Friday to treat emergency allergic reactions in adults and children — the first injection-free alternative to shots like EpiPen. The ...
A new study has found that a concentrated 2mg intranasal naloxone spray delivers naloxone as effectively, over the critical first 15 minutes, as the standard 0.4mg intramuscular (IM) naloxone ...
On Friday, the FDA approved ARS Pharmaceuticals Inc’s (NASDAQ:SPRY) neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those that are ...
It's been available in the northern hemisphere for years, now Australian children can receive a nasal spray vaccine for the ...
ATHENS, Ga. — While during the pandemic, vaccines were all shots in the arm, researchers in Georiga are working on a new COVID-19 vaccine that may not be. At the University of Georgia, researchers are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results